Exact Mass: 466.09

Exact Mass Matches: 466.09

Found 19 metabolites which its exact mass value is equals to given mass value 466.09, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

BL IV

3,4-Bis(acetyloxy)-11,12-dihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6,10,12-hexaen-6-yl acetic acid

C24H18O10 (466.09)


BL IV is found in mushrooms. BL IV is a constituent of the kurukawa mushroom (Boletopsis leucomelas) (edibility not reported)

   

(4-Chlorophenyl) (1R)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

6-Chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-, 4-chlorophenyl ester, (1S)-2H-pyrido(3,4-b)indole-2-carboxylic acid

C25H20Cl2N2O3 (466.0851)


   

EP_M467

EP_M467

C20H20ClFN4O4S (466.0878)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2204

   

CHEMBL608844

CHEMBL608844

C17H18N6O8S (466.0907)


   

Deacetylkirschsteinin

Deacetylkirschsteinin

C24H18O10 (466.09)


   

eriocephaloside

eriocephaloside

C24H18O10 (466.09)


   

MMV687700

MMV687700

C17H18N6O8S (466.0907)


   

cromolyn

cromolyn

C24H18O10 (466.09)


   

Ziprasidone Hydrochloride Monohydrate

Ziprasidone Hydrochloride Monohydrate

C21H24Cl2N4O2S (466.0997)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ziprasidone (CP-88059) hydrochloride monohydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone hydrochloride monohydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].

   

Varlitinib

Varlitinib

C22H19ClN6O2S (466.0979)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid

2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid

C21H23ClN2O6S (466.0965)


   

(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

C25H20Cl2N2O3 (466.0851)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   

Salicyl-AMS

Salicyl-AMS

C17H18N6O8S (466.0907)


   

S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine

S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine

C20H20ClFN4O4S (466.0878)


   

5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate

5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate

C21H24Cl2N4O2S (466.0997)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide

N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide

C23H19ClN4O3S (466.0866)


   

3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate

3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate

C24H18O10 (466.09)


   

17-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

17-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

C24H18O10 (466.09)


   

17-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

17-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

C24H18O10 (466.09)